{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Background+Chemotherapy&page=2", "query": { "intervention": "Background Chemotherapy", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Background+Chemotherapy&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-09-25T16:32:34.737Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01974440", "title": "A Study of PCI-32765 (Ibrutinib) in Combination With Either Bendamustine and Rituximab or Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Participants With Previously Treated Indolent Non-Hodgkin Lymphoma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Lymphoma" ], "interventions": [ { "name": "Bendamustine", "type": "DRUG" }, { "name": "Rituximab", "type": "DRUG" }, { "name": "Cyclophosphamide", "type": "DRUG" }, { "name": "Doxorubicin", "type": "DRUG" }, { "name": "Vincristine", "type": "DRUG" }, { "name": "Prednisone", "type": "DRUG" }, { "name": "PCI-32765 (Ibrutinib)", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Janssen Research & Development, LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 403, "start_date": "2014-01-31", "completion_date": "2023-06-21", "has_results": true, "last_update_posted_date": "2025-05-25", "last_synced_at": "2026-09-25T16:32:34.737Z", "location_count": 32, "location_summary": "Gilbert, Arizona • Campbell, California • Duarte, California + 29 more", "locations": [ { "city": "Gilbert", "state": "Arizona" }, { "city": "Campbell", "state": "California" }, { "city": "Duarte", "state": "California" }, { "city": "La Jolla", "state": "California" }, { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01974440" }, { "nct_id": "NCT04929899", "title": "Bright Ideas - CIN Feasibility Study", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Acute Lymphoblastic Leukemia (ALL)" ], "interventions": [ { "name": "Bright Ideas - CIN Training", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "The Hospital for Sick Children", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "4 Years", "maximum_age": "18 Years", "sex": "ALL", "summary": "4 Years to 18 Years" }, "enrollment_count": 75, "start_date": "2022-03-01", "completion_date": "2025-06", "has_results": false, "last_update_posted_date": "2025-01-31", "last_synced_at": "2026-09-25T16:32:34.737Z", "location_count": 3, "location_summary": "Los Angeles, California • New Brunswick, New Jersey • Falls Church, Virginia", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "New Brunswick", "state": "New Jersey" }, { "city": "Falls Church", "state": "Virginia" } ], "official_url": "https://clinicaltrials.gov/study/NCT04929899" }, { "nct_id": "NCT06623422", "title": "A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Carcinoma, Non-Small-Cell Lung" ], "interventions": [ { "name": "Pembrolizumab", "type": "BIOLOGICAL" }, { "name": "Cisplatin", "type": "DRUG" }, { "name": "Carboplatin", "type": "DRUG" }, { "name": "Pemetrexed", "type": "DRUG" }, { "name": "Gemcitabine", "type": "DRUG" }, { "name": "Paclitaxel", "type": "DRUG" }, { "name": "Intismeran autogene", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "BIOLOGICAL", "DRUG", "OTHER" ], "sponsor": "Merck Sharp & Dohme LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 680, "start_date": "2024-10-21", "completion_date": "2038-01-26", "has_results": false, "last_update_posted_date": "2026-09-18", "last_synced_at": "2026-09-25T16:32:34.737Z", "location_count": 52, "location_summary": "Gilbert, Arizona • Tucson, Arizona • Fullerton, California + 40 more", "locations": [ { "city": "Gilbert", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Fullerton", "state": "California" }, { "city": "Long Beach", "state": "California" }, { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06623422" }, { "nct_id": "NCT02605343", "title": "Prospective Observational Clinical Study to Evaluate Patient Outcomes Following Pharmacogenetic Testing of Patients Undergoing Elective Surgical Procedures", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Acute Pain", "Surgery" ], "interventions": [ { "name": "NeuroIDgenetix Test Panel", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "AltheaDx", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 110, "start_date": "2015-08", "completion_date": "2016-04", "has_results": false, "last_update_posted_date": "2016-06-06", "last_synced_at": "2026-09-25T16:32:34.737Z", "location_count": 1, "location_summary": "Cleveland, Ohio", "locations": [ { "city": "Cleveland", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT02605343" }, { "nct_id": "NCT02599870", "title": "Clinical Study to Evaluate Clinical Impact of PGx-Guided Treatment for Patients Undergoing Elective Spinal Surgical Procedures", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Acute Pain", "Surgery" ], "interventions": [ { "name": "NeuroIDgenetix Test Panel", "type": "GENETIC" } ], "intervention_types": [ "GENETIC" ], "sponsor": "AltheaDx", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "99 Years", "sex": "ALL", "summary": "18 Years to 99 Years" }, "enrollment_count": 56, "start_date": "2015-09", "completion_date": "2016-02", "has_results": false, "last_update_posted_date": "2018-07-09", "last_synced_at": "2026-09-25T16:32:34.737Z", "location_count": 1, "location_summary": "New Orleans, Louisiana", "locations": [ { "city": "New Orleans", "state": "Louisiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT02599870" }, { "nct_id": "NCT01712009", "title": "NOLAN: Naproxen or Loratadine and Neulasta", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Bone Pain in Stage I - III Breast Cancer" ], "interventions": [ { "name": "Naproxen", "type": "DRUG" }, { "name": "Loratadine", "type": "DRUG" }, { "name": "Pegfilgrastim", "type": "BIOLOGICAL" }, { "name": "Chemotherapy", "type": "DRUG" } ], "intervention_types": [ "DRUG", "BIOLOGICAL" ], "sponsor": "Amgen", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "100 Years", "sex": "FEMALE", "summary": "18 Years to 100 Years · Female only" }, "enrollment_count": 600, "start_date": "2012-11-01", "completion_date": "2015-03-18", "has_results": true, "last_update_posted_date": "2018-01-30", "last_synced_at": "2026-09-25T16:32:34.737Z", "location_count": 83, "location_summary": "Muscle Shoals, Alabama • Anaheim, California • Fullerton, California + 78 more", "locations": [ { "city": "Muscle Shoals", "state": "Alabama" }, { "city": "Anaheim", "state": "California" }, { "city": "Fullerton", "state": "California" }, { "city": "Santa Maria", "state": "California" }, { "city": "Santa Rosa", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01712009" }, { "nct_id": "NCT00109603", "title": "Effect of Tenofovir Disoproxil Fumarate on Lipid Levels in HIV Infected Adults on Stable Anti-HIV Drug Therapy", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "HIV Infections", "Dyslipidemia", "Hyperlipidemia", "Hypercholesterolemia", "Hypertriglyceridemia" ], "interventions": [ { "name": "Tenofovir disoproxil fumarate", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 17, "start_date": "2005-05", "completion_date": "2007-11", "has_results": false, "last_update_posted_date": "2012-10-30", "last_synced_at": "2026-09-25T16:32:34.737Z", "location_count": 19, "location_summary": "Los Angeles, California • San Diego, California • Denver, Colorado + 11 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Denver", "state": "Colorado" }, { "city": "Miami", "state": "Florida" }, { "city": "Indianapolis", "state": "Indiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT00109603" }, { "nct_id": "NCT00559585", "title": "Methotrexate-Inadequate Response Study", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Rheumatoid Arthritis (RA)" ], "interventions": [ { "name": "Subcutaneous (SC) Abatacept", "type": "DRUG" }, { "name": "Intravenous (IV) Abatacept", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Bristol-Myers Squibb", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 2492, "start_date": "2008-01", "completion_date": "2014-09", "has_results": true, "last_update_posted_date": "2015-11-09", "last_synced_at": "2026-09-25T16:32:34.737Z", "location_count": 70, "location_summary": "Birmingham, Alabama • Mobile, Alabama • Scottsdale, Arizona + 63 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Scottsdale", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Hot Springs", "state": "Arkansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00559585" }, { "nct_id": "NCT00002368", "title": "The Safety and Effectiveness of Nevirapine Plus Lamivudine Plus Other Anti-HIV Drugs", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "HIV Infections" ], "interventions": [ { "name": "Nevirapine", "type": "DRUG" }, { "name": "Lamivudine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Boehringer Ingelheim", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "13 Years", "maximum_age": null, "sex": "ALL", "summary": "13 Years and older" }, "enrollment_count": 2000, "start_date": null, "completion_date": null, "has_results": false, "last_update_posted_date": "2005-06-24", "last_synced_at": "2026-09-25T16:32:34.737Z", "location_count": 53, "location_summary": "Montgomery, Alabama • Los Angeles, California • Palo Alto, California + 41 more", "locations": [ { "city": "Montgomery", "state": "Alabama" }, { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Palo Alto", "state": "California" }, { "city": "Redwood City", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00002368" }, { "nct_id": "NCT01695993", "title": "Alternative Approaches for Nausea Control", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Nausea" ], "interventions": [ { "name": "Acupressure bands", "type": "DEVICE" }, { "name": "Expectancy-neutral handout", "type": "OTHER" }, { "name": "Expectancy-neutral MP3", "type": "BEHAVIORAL" }, { "name": "Expectancy-enhancing handout", "type": "OTHER" }, { "name": "Expectancy-enhancing MP3", "type": "BEHAVIORAL" } ], "intervention_types": [ "DEVICE", "OTHER", "BEHAVIORAL" ], "sponsor": "University of Rochester", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 242, "start_date": "2012-11", "completion_date": "2017-05-16", "has_results": true, "last_update_posted_date": "2018-06-26", "last_synced_at": "2026-09-25T16:32:34.737Z", "location_count": 4, "location_summary": "Buffalo, New York • East Syracuse, New York • Rochester, New York", "locations": [ { "city": "Buffalo", "state": "New York" }, { "city": "East Syracuse", "state": "New York" }, { "city": "Rochester", "state": "New York" }, { "city": "Rochester", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT01695993" } ] }